RETAVASE Side Effects

6992377-8 | Incorrect Dose Administered, Prothrombin Time Shortened
on Sep 01, 2010 Male patient from GERMANY , 69 years of age, was treated with Retavase (View Usage). Patient experienced the following unwanted or unexpected effects: incorrect dose administered, prothrombin time shortened. Retavase dosage: ;iv.

6423143-X | Haemorrhage
Patient was taking Retavase (View Usage). Patient had the following side effects: haemorrhage on Dec 03, 2008 from UNITED STATES Additional patient health information: Female patient , 57 years of age, was diagnosed with pulmonary embolism (What is pulmonary embolism?) and. Retavase dosage: 10 U; X1; Ia.

6160055-3 | Cerebral Haemorrhage, Visual Acuity Reduced
Adverse event was reported on Mar 30, 2009 by a Male patient taking Retavase (View Usage) (Dosage: ) was diagnosed with acute myocardial infarction and. Location: UNITED STATES , 65 years of age, weighting 165.0 lb, After Retavase was administered, patient had the following side effects: cerebral haemorrhage, visual acuity reduced. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

5608942-6 | Arterial Disorder, Cardio-respiratory Arrest, Haemorrhage Intracranial, Pneumonia
on Jan 29, 2008 Male patient from UNITED STATES , weighting 149.9 lb, was diagnosed with arterial occlusive disease and was treated with Retavase (View Usage). Patient experienced the following unwanted or unexpected effects: arterial disorder, cardio-respiratory arrest, haemorrhage intracranial, pneumonia (What is pneumonia?). Retavase dosage: 1 Unit/hr Continuous Iv Drip. During the same period patient was treated with HEPARIN (500 Units/hr Continuous Iv Drip) (View Heparin Review and Heparin Label ).


5442405-6 | Aggression, Agitation, Blood Glucose Increased, Bundle Branch Block Left, Cardiac Failure Congestive, Condition Aggravated, Dehydration, Fall, Haemoglobin Decreased
on Aug 16, 2007 Male patient from UNITED STATES , 74 years of age, weighting 155.2 lb, was diagnosed with acute myocardial infarction and was treated with Retavase (View Usage). Patient had the following side effects: aggression, agitation, blood glucose increased, bundle branch block left, cardiac failure congestive, condition aggravated, dehydration, fall (What is fall?), haemoglobin decreased. Retavase dosage: 5 Iu; Bid; Iv. During the same period patient was treated with ABCIXIMAB (9.6 Mg; X1; Iv, 208 Mg; X1; Iv) (View Abciximab Review and Abciximab Label ), DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), LASIX (View Lasix Review and Lasix Label ), COREG (View Coreg Review and Coreg Label ), VASOTEC (View Vasotec Review and Vasotec Label ).

5442404-4 | Chest Pain
Patient was taking Retavase (View Usage). After Retavase was administered, patient had the following side effects: chest pain (What is chest pain?) on Aug 16, 2007 from UNITED STATES Additional patient health information: Female patient , 55 years of age, was diagnosed with acute myocardial infarction and. Retavase dosage: 5 Iu; Bid; Iv. During the same period patient was treated with ABCIXIMAB (10 Mg; X1; Iv, 3.5 Mg; X1; Iv) (View Abciximab Review and Abciximab Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ). Patient was hospitalized.

5369893-8 | Acute Myocardial Infarction, Bronchopneumonia, Cardiac Arrest, Coronary Artery Occlusion, Haemodynamic Instability, Multi-organ Failure, Rales, Sepsis
Adverse event was reported on Jun 06, 2007 by a Female patient taking Retavase (View Usage) (Dosage: Iv) was diagnosed with acute myocardial infarction and. Location: UNITED KINGDOM , 73 years of age, weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, bronchopneumonia, cardiac arrest (What is cardiac arrest?), coronary artery occlusion, haemodynamic instability, multi-organ failure, rales, sepsis (What is sepsis?). During the same period patient was treated with ABCIXIMAB (Iv) (View Abciximab Review and Abciximab Label ), INSULIN HUMAN (View Insulin Human Review and Insulin Human Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ATOVASTATIN (View Atovastatin Review and Atovastatin Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ).